Nicolas Kattán, MD

Nick Kattan Villegas

Nick Kattan Villegas M.D.

Associate Division Chief
Department: MD-HOSPITAL MEDICINE DIVISION
Mailing Address:
PO Box 100238
GAINESVILLE FL 32610
Physical Address:
PO Box 100238
GAINESVILLE FL 32610
Accomplishments:
  • Excellence in Teaching Award
    2019 · University of Florida. Department of Medicine
  • Master Clinician Award
    2015 · University of Florida. Department of Medicine
  • Humanitarian Award
    2011 · John H. Jr. Hospital of Cook County. Departmet of Medicine
  • General Medicine Award of Excellence
    2011 · John H. Jr. Hospital of Cook County. Department of Medicine
  • Student Education Award
    2009 · John H. Jr. Hospital of Cook County. Department of Medicine
Certifications:
  • General Internal Medicine
    American Board of Internal Medicine (ABIM)
  • Infectious Disease
    American Board of Internal Medicine (ABIM)
Specialties:
  • Hospital Medicine
Clinical Interests:
  • Infectious diseases
Publications:
Grants:
  • Jan 2024 ACTIVE
    EPIC-WELL: Electronic Performance Indicators for Clinical Workload and Physician Well-Being in Inpatient Settings
    UNIV OF COLORADO DENVER & ANSCHUTZ MED · Co-Investigator
Education:
  • 2013
    Fellowship – Infectious Disease
    John H. Stroger, Jr. Hospital of Cook County
  • 2011
    Residency – Internal Medicine
    John H. Stroger, Jr. Hospital of Cook County
  • 2009
    Internship – Internal Medicine
    John H. Stroger, Jr. Hospital of Cook County
  • 2005
    Medical Degree
    Universidad del Valle

About Dr. Kattan

program/degree institution field/specialty
M.D. Universidad del Valle Medicine
Residency John H. Stroger Jr. Hospital of Cook County Internal Medicine
Fellowship Cleveland Clinic Foundation Infectious Diseases

Publications/Research:

  • Kattan JN, Villegas MV, Quinn JP. “New Developments in Carbapenems” Clin Microbiol Infect 2008 Dec;14(12):1102-11. PMID: 19076841.
  • Villegas MV, Kattan JN, Quinteros MG, Casellas JM. “Prevalence of Extended Spectrum Beta-lactamases (ESBLs) in South America” Clin Microbiol Infect. 2008 Jan;14 Suppl 1:154-8. Erratum in: Clin Microbiol Infect. 2008. May;14 Suppl 5:21-4.. PMID: 18154539
  • Villegas MV, Kattan JN, Correa A, Lolans K, Guzman AM, Woodford N, Livermore D, Quinn JP and the Colombian Nosocomial Bacterial Resistance Study Group. “Acinetobacter Baumannii con Carbapenemasa OXA-23 en Colombia” Rev Chil Infect 2007; 24 (6): 500-503.
  • Villegas MV, Kattan JN, Correa A, Lolans K, Guzman AM, Woodford N, Livermore D, Quinn JP and the Colombian Nosocomial Bacterial Resistance Study Group. “Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals” Antimicrob Agents Chemother 2007; 51(6):2001-4. PMID: 17403994
  • Villegas MV, Lolans K, Correa A, Kattan JN, Lopez J and Quinn JP. “First Identification of Pseudomonas Aeruginosa Isolates Producing a KPC-type Carbapenem-hydrolyzing Beta-lactamase” Antimicrob Agents Chemother 2007; 51(4):1553-5. PMID: 17261621.
  • Suarez CJ, Kattan JN, Guzman AM, Villegas MV. “Mecanismos de Resistencia a Carbapenems en P. Aeruginosa, Acinetobacter y
    Enterobacteriaceae y Estrategias para su Prevención y Control” Infectio 2006; 10(2):85-93.